Sonnet BioTherapeutics Holdings
New Jersey, United States · Biotechnology, Healthcare
Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage company developing targeted immunotherapeutic drugs.
Key facts
- Headquarters
- New Jersey, United States
- Employees
- 17
- Industries
- Biotechnology, Healthcare
- Status
- Private
- Website
- sonnetbio.com
- Company page
Recent activity at Sonnet BioTherapeutics Holdings
- : Sonnet BioTherapeutics Appoints Stephen J. McAndrew, Ph.D., as Chief Business Officer
- : Sonnet BioTherapeutics Holdings
- : Sonnet BioTherapeutics Enters Master Clinical Collaboration Agreement with Sarcoma Oncology Center for the Development of SON-1210 in Pancreatic Cancer Treatment
- : Sonnet Biotherapeutics, Inc.
Sonnet BioTherapeutics Holdings funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Seed | $3.9M |
| May 2019 | Seed | $750K |
Leadership
- Pankaj Mohan, Executive Officer, Director
- Stephen J. McAndrew, Chief Business Officer
- John K. Cini, Founder
- Jay Cross, Chief Financial Officer
- Susan Dexter, Executive Officer
- Terence Rugg, Executive Officer
- John Cini, Executive Officer
- Donald Griffith, Executive Officer
Verified email and direct lines for Sonnet BioTherapeutics Holdings’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Sonnet BioTherapeutics Holdings files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Sonnet BioTherapeutics Holdings in the news
Companies similar to Sonnet BioTherapeutics Holdings
- Aspargo Laboratories · Biotechnology, Healthcare
- CervoMed · Biotechnology, Healthcare
- CalciMedica · Biotechnology, Healthcare
- Medicus Pharma · Biotechnology, Healthcare
- Sydnexis · Biotechnology, Healthcare
About Sonnet BioTherapeutics Holdings: questions and answers
What does Sonnet BioTherapeutics Holdings do?
Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage company developing targeted immunotherapeutic drugs.
Where is Sonnet BioTherapeutics Holdings headquartered?
Sonnet BioTherapeutics Holdings is headquartered in New Jersey, United States.
How many employees does Sonnet BioTherapeutics Holdings have?
Sonnet BioTherapeutics Holdings has about 17 employees.
Has Sonnet BioTherapeutics Holdings raised funding?
Yes. Fundz has recorded 2 funding events for Sonnet BioTherapeutics Holdings. The most recent, Seed of $3.9M, was in Dec 2024.
Who leads Sonnet BioTherapeutics Holdings?
John K. Cini is a Founder at Sonnet BioTherapeutics Holdings.
What is the latest news on Sonnet BioTherapeutics Holdings?
On Feb 13, 2025, Sonnet BioTherapeutics Appoints Stephen J. McAndrew, Ph.D., as Chief Business Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy